Last reviewed · How we verify

NCT05081154

CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches

Completed NA Last updated 27 June 2022
What this trial tests

NA trial testing Product A in Smoking in 36 participants. Completed in 24 November 2021.

Timeline
20 October 2021
Primary endpoint
24 November 2021
24 November 2021

Quick facts

Lead sponsorRAI Services Company
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment36
Start date20 October 2021
Primary completion24 November 2021
Estimated completion24 November 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

RAI Services Company

Who can join

Adults 21 to 60, any sex, with Smoking or Tobacco Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-center, open-label, randomized, 7-way crossover study designed to evaluate plasma nicotine pharmacokinetics (PK) parameters following use of the study investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized crossover clinical studies to assess abuse liability and nicotine pharmacokinetics of Velo Oral Nicotine pouches.
    Kanobe MN, Powell CY, Patrudu M, Baxter SA, et al · · 2025 · cited 2× · PMID 40183092 · DOI 10.3389/fphar.2025.1547073

Verify or expand the search:

Other trials of Product A

Trials testing the same drug.

Other recruiting trials for Smoking

Currently open trials in the same condition.

Other RAI Services Company trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05081154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing